Connor, Clark & Lunn Investment Management (CC&L)
ANAB icon

Connor, Clark & Lunn Investment Management (CC&L)’s AnaptysBio ANAB Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.52M Sell
141,026
-17,536
-11% -$1.06M 0.02% 552
2026
Q1 		$8.79M Buy
158,562
+36,086
+29% +$1.94M 0.02% 510
2025
Q4 		$5.94M Buy
+122,476
New +$4.77M 0.02% 597
2023
Q1 		– Sell
-28,465
Closed -$882K – 1229
2022
Q4 		$882K Sell
28,465
-37,369
-57% -$1.06M 0.01% 737
2022
Q3 		$1.68M Sell
65,834
-7,444
-10% -$174K 0.01% 530
2022
Q2 		$1.49M Sell
73,278
-5,149
-7% -$114K 0.01% 531
2022
Q1 		$1.94M Sell
78,427
-9,642
-11% -$292K 0.01% 506
2021
Q4 		$3.06M Buy
88,069
+187
+0.2% +$5.93K 0.01% 437
2021
Q3 		$2.38M Buy
87,882
+7,733
+10% +$196K 0.01% 490
2021
Q2 		$2.08M Buy
80,149
+1,532
+2% +$36.7K 0.01% 531
2021
Q1 		$1.69M Buy
78,617
+3,000
+4% +$75.7K 0.01% 598
2020
Q4 		$1.63M Sell
75,617
-11,834
-14% -$287K 0.01% 553
2020
Q3 		$1.29M Sell
87,451
-19,340
-18% -$349K 0.01% 572
2020
Q2 		$2.39M Sell
106,791
-2,109
-2% -$38.6K 0.02% 420
2020
Q1 		$1.54M Buy
108,900
+18,600
+21% +$282K 0.01% 471
2019
Q4 		$1.47M Buy
+90,300
New +$2.14M 0.01% 473

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ANAB Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its AnaptysBio (ANAB) stake by 11% in Q2 2026, selling an estimated $1.06M and leaving 141,026 shares worth $9.52M. The position accounts for 0.02% of the portfolio, ranked #552.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ANAB in Q4 2019 and has held it in 16 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 141,026 shares of AnaptysBio worth $9.52M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 17,536 AnaptysBio shares in Q2 2026, an estimated $1.06M.
  • AnaptysBio made up 0.02% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #552 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AnaptysBio in Q4 2019 and has held it in 16 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.